Cambridge Innovation Capital
Cambridge, UK
Quick Facts
- AUM
- $500M
- AUM Category
- $100M-$500M
- Typical Ticket Size
- $5M - $20M
- Headquarters
- Cambridge, UK
- Founded
- 2013
- Team Size
- 10-50
About Cambridge Innovation Capital
Cambridge Innovation Capital (CIC) is a private equity firm based in the United Kingdom, with a strong focus on investing in technology and innovation-driven companies. The firm follows a distinct investment philosophy that emphasizes the potential for transformative growth within its portfolio. By adopting a long-term investment horizon, CIC seeks to partner with companies that demonstrate not only significant market potential but also a capacity for innovation and scalability. Their typical deal thesis revolves around identifying and nurturing high-potential businesses that leverage advanced technologies, particularly in the sectors of life sciences, technology, and advanced manufacturing. CIC has developed deep sector expertise, particularly in the fields of healthcare, software, and digital technologies. The firm targets companies that are often in the early to growth stages, where its capital and strategic support can catalyze development and market entry. Their focus on high-growth sectors enables them to capitalize on emerging trends and shifts in technology, which is critical in a rapidly evolving market landscape. The firm’s portfolio includes a range of companies that are not only innovative but also have the potential for substantial impact in their respective industries. What distinguishes Cambridge Innovation Capital in the private equity landscape is its strong ties to the Cambridge ecosystem—a hub of academic and technological excellence. This connection provides CIC with unique access to cutting-edge research, talent, and collaborative opportunities with leading institutions. The firm’s approach to investment is deeply intertwined with its commitment to fostering innovation, making it an attractive partner for companies looking to leverage the latest advancements in science and technology. For interim executives considering collaboration with CIC, it is essential to understand the firm’s emphasis on strategic value creation. CIC seeks executives who can not only drive operational improvements but also contribute to the long-term vision of its portfolio companies. Executives with a track record in innovation-led environments, particularly those who can navigate the complexities of high-tech industries, will find a particularly receptive audience at CIC. Partnering with this firm can provide opportunities to engage in transformative projects that align with their mission of driving sustainable growth through innovation.
Investment Focus
Sectors: Technology, Healthcare
Investment Stages: Venture, Growth
Portfolio Focus: B2B, HealthTech, DeepTech
Regional Offices
- London
Connect with Cambridge Innovation Capital
Frequently Asked Questions
- Is Cambridge Innovation Capital a private equity firm?
- Yes, Cambridge Innovation Capital is a private equity firm headquartered in Cambridge, UK, founded in 2013.
- What is Cambridge Innovation Capital's AUM (assets under management)?
- Cambridge Innovation Capital manages approximately $500M in assets under management.
- What is Cambridge Innovation Capital's typical ticket size?
- Cambridge Innovation Capital typically invests $5M - $20M per deal.
- Where is Cambridge Innovation Capital headquartered?
- Cambridge Innovation Capital is headquartered in Cambridge, UK. Regional offices include London.
- What sectors does Cambridge Innovation Capital invest in?
- Cambridge Innovation Capital invests across Technology, Healthcare.
- What investment stages does Cambridge Innovation Capital focus on?
- Cambridge Innovation Capital focuses on Venture, Growth investments.
- When was Cambridge Innovation Capital founded?
- Cambridge Innovation Capital was founded in 2013.
Profile data is compiled from publicly available sources and AI analysis for the Interim community. Information is not endorsed by Cambridge Innovation Capital; verify critical details directly with the firm.